810222P
Avanti
C6-NBD Glucosyl Ceramide
Avanti Research™ - A Croda Brand
别名:
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-β1-1′-sphingosine
产品名称
C6-NBD Glucosyl Ceramide, Avanti Research™ - A Croda Brand 810222P, powder
方案
>99% (TLC)
表单
powder
包装
pkg of 1 × 1 mg (810222P-1MG)
pkg of 1 × 250 μg (810222P-250ug)
制造商/商品名称
Avanti Research™ - A Croda Brand 810222P
运输
dry ice
储存温度
−20°C
生化/生理作用
The synthesis of glucosyl ceramide (GlcCer) occurs in the cytosolic membranes of Golgi. It is catalysed by GlcCer synthase. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids. C6-NBD glcCer is useful to view ceramide rich membrane domains in Golgi compartments.
包装
5 mL Amber Glass Screw Cap Vial (810299P-1MG)
5 mL Clear Glass Sealed Ampule (810222P-250ug)
法律信息
Avanti Research is a trademark of Avanti Polar Lipids, LLC
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
No data available
闪点(°C)
No data available
法规信息
新产品
此项目有
A functionalized sphingolipid analogue for studying redistribution during activation in living T cells
Collenburg L, et al.
Journal of Immunology, 196(9), 3951-3962 (2016)
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
D?Angelo G, et al.
Nature, 449(7158), 62-62 (2007)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持